Dr. Kohan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
480 Hicksville Road
Bethpage, NY 11714Phone+1 516-796-2222Fax+1 516-796-2303
Education & Training
Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Urology, 1995 - 1999- Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Surgery, 1993 - 1995
Icahn School of Medicine at Mount SinaiClass of 1993
Certifications & Licensure
NY State Medical License 1997 - 2026- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2012-2013
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 36 citationsThe iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, ...Bilal Chughtai, Dean Elterman, Neal D. Shore, Marc Gittleman, Jay Motola
Urology. 2021-07-01 - 8 citationsSafety, tolerability, and efficacy of LiRIS 400 mg in women with interstitial cystitis/bladder pain syndrome with or without Hunner lesionsRobert J. Evans, Alfred Kohan, Robert M. Moldwin, Daniel Radecki, Till Geib
Neurourology and Urodynamics. 2021-07-20 - 23 citationsThe Efficacy and Safety of OnabotulinumtoxinA or Solifenacin Compared with Placebo in Solifenacin Naïve Patients with Refractory Overactive Bladder: Results from a Mul...Sender Herschorn, Alfred Kohan, Philip J. Aliotta, Kurt A. McCammon, Rajagopalan Sriram
The Journal of Urology. 2017-07-01
Journal Articles
- Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of TreatmentAlfred Kohan, Eric Rovner, Victor Nitti, The Journal of Urology
- Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of TreatmentEric Rovner, Victor Nitti, Alfred Kohan, The Journal of Urology
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
